Discontinuation report SODIUM BICARBONATE INJECTION, USP
| Report ID | 239180 |
| Drug Identification Number | 02486628 |
| Brand name | SODIUM BICARBONATE INJECTION, USP |
| Common or Proper name | SODIUM BICARBONATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM BICARBONATE |
| Strength(s) | 42MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-09-10 |
| Remaining supply date | 2024-09-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No stock available. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-10-03 | French | Compare |
| v1 | 2024-10-03 | English | Compare |
Showing 1 to 2 of 2